- Home
- KNSA vs CNCK Comparison
KNSA vs CNCK Comparison
Compare KNSA & CNCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- CNCK
- Stock Information
- Founded
- KNSA 2015
- CNCK 2012
- Country
- KNSA United Kingdom
- CNCK Netherlands
- Employees
- KNSA N/A
- CNCK N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- CNCK
- Sector
- KNSA Health Care
- CNCK
- Exchange
- KNSA Nasdaq
- CNCK NYSE
- Market Cap
- KNSA 1.3B
- CNCK 1.3B
- IPO Year
- KNSA 2018
- CNCK N/A
- Fundamental
- Price
- KNSA $18.73
- CNCK $9.15
- Analyst Decision
- KNSA Strong Buy
- CNCK
- Analyst Count
- KNSA 5
- CNCK 0
- Target Price
- KNSA $36.60
- CNCK N/A
- AVG Volume (30 Days)
- KNSA 469.7K
- CNCK 126.5K
- Earning Date
- KNSA 02-26-2025
- CNCK 01-01-0001
- Dividend Yield
- KNSA N/A
- CNCK N/A
- EPS Growth
- KNSA N/A
- CNCK N/A
- EPS
- KNSA N/A
- CNCK 9.67
- Revenue
- KNSA $384,098,000.00
- CNCK $2,137,054,786.00
- Revenue This Year
- KNSA $60.05
- CNCK N/A
- Revenue Next Year
- KNSA $36.74
- CNCK N/A
- P/E Ratio
- KNSA N/A
- CNCK $1.02
- Revenue Growth
- KNSA 54.41
- CNCK 52.57
- 52 Week Low
- KNSA $16.56
- CNCK $6.55
- 52 Week High
- KNSA $28.15
- CNCK $14.99
- Technical
- Relative Strength Index (RSI)
- KNSA 38.56
- CNCK N/A
- Support Level
- KNSA $18.27
- CNCK N/A
- Resistance Level
- KNSA $19.05
- CNCK N/A
- Average True Range (ATR)
- KNSA 0.61
- CNCK 0.00
- MACD
- KNSA -0.05
- CNCK 0.00
- Stochastic Oscillator
- KNSA 34.42
- CNCK 0.00
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About CNCK COINCHECK GROUP NV
Coincheck Group NV is a digital asset trading service company. It operates multi-cryptocurrency marketplaces and crypto asset exchanges in Japan and marketplace and exchange platforms on which diverse cryptocurrencies, including Bitcoin and Ethereum, are held and exchanged, and offers other retail-focused crypto services. It is also increasing user's access to digital products and solutions beyond cryptocurrencies, such as non-fungible tokens (NFTs). The company manages its business in one operating and reportable segment: Crypto Asset.